OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility that was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction. The full announcement is available at https://ibn.fm/G0Fj3.
This credit facility provides OptimizeRx with substantial financial flexibility to support its growth initiatives, including product development, strategic acquisitions, and working capital needs. The company has been expanding its platform, which combines innovative artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement between life science brands and healthcare providers or patients.
OptimizeRx is a leading healthcare technology company that bridges the gap between HCP and DTC strategies, empowering brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes. The company's commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time.
Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape. The new credit facility is expected to accelerate these efforts by providing the capital necessary to invest in advanced technologies and expand market reach. The undrawn revolving credit facility offers additional liquidity for future opportunities, enhancing the company's ability to respond to market dynamics.
The importance of this funding cannot be overstated, as it enables OptimizeRx to continue its mission of redefining how life science brands connect with patients and healthcare providers. With the healthcare industry increasingly relying on digital solutions, the company is well-positioned to capitalize on trends such as personalized medicine and data-driven marketing. The support from Fifth Third Bank underscores confidence in OptimizeRx's business model and growth prospects.
For more information about OptimizeRx, visit www.optimizerx.com. The company's platform addresses a critical need in the healthcare ecosystem: improving patient outcomes through timely and relevant engagement. As the industry continues to evolve, OptimizeRx's technology-driven approach is likely to become increasingly vital.
